Study Protocol for Pleiotropic Effects and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
Yumie TakeshitaTakehiro KanamoriTakeo TanakaYuka KaikoiYuki KitaNoboru TakataNoriho IidaKuniaki AraiTatsuya YamashitaKenichi HaradaToshifumi GabataHiroyuki NakamuraShuichi KanekoToshinari TakamuraPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
This trial is registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN000020544) and ClinicalTrials.gov (NCT02649465).